Pendekatan Molecular Docking dalam Metode Penemuan Obat Berbasis Struktur: Sebuah Tinjauan
DOI:
https://doi.org/10.15408/pbsj.v8i1.50146Keywords:
molecular docking, hit identification, drug design, CADD, virtual screeningAbstract
Molecular docking is one of the most widely used computational techniques in computer-aided drug design (CADD) for predicting ligand binding modes and relative binding affinities toward target proteins. Although binding affinity is frequently used to evaluate docking performance, the success of molecular docking cannot be determined by a single parameter. Instead, predictive accuracy depends on the integration of multiple interrelated methodological factors. This review discusses the fundamental principles, methodologies, validation strategies, and interpretation of molecular docking in the context of structure-based drug discovery. The topics covered include protein structure quality, conformational search algorithms, scoring functions, docking workflows, and protein–ligand interaction analysis. This review highlights that the accuracy of molecular docking relies on the integration of all methodological stages, from protein structure selection to validation and result interpretation. It provides a comprehensive overview of molecular docking as an effective tool for initial screening and hypothesis generation in structure-based drug discovery prior to further validation using molecular dynamics simulations and experimental studies.
References
Agu, P.C. et al. (2023) ‘Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management’, Scientific Reports, 13(1), p. 13398. Available at: https://doi.org/10.1038/s41598-023-40160-2.
Aguiar, C. and Camps, I. (2024) ‘Molecular Docking in Drug Discovery: Techniques, Applications, and Advancements’. Available at: https://doi.org/10.26434/chemrxiv-2024-gmhtx.
Banari, A. et al. (2025) ‘Advancing time-resolved structural biology: latest strategies in cryo-EM and X-ray crystallography’, Nature Methods, 22(7), pp. 1420–1435. Available at: https://doi.org/10.1038/s41592-025-02659-6.
Batool, M., Ahmad, B. and Choi, S. (2019) ‘A Structure-Based Drug Discovery Paradigm’, International Journal of Molecular Sciences, 20(11), p. 2783. Available at: https://doi.org/10.3390/ijms20112783.
Bhatt, A. et al. (2024) ‘Mapping of Global Research Performance on Molecular Docking: A Bibliometric Study’, Current Trends in Biotechnology and Pharmacy, 18(2), pp. 1725–1735. Available at: https://doi.org/10.5530/ctbp.2024.2.21.
Bjerrum, E.J. (2016) ‘Machine learning optimization of cross docking accuracy’, Computational Biology and Chemistry, 62, pp. 133–144. Available at: https://doi.org/10.1016/j.compbiolchem.2016.04.005.
Bulusu, G. and Desiraju, G.R. (2020) ‘Strong and Weak Hydrogen Bonds in Protein–Ligand Recognition’, Journal of the Indian Institute of Science, 100(1), pp. 31–41. Available at: https://doi.org/10.1007/s41745-019-00141-9.
Burley, S.K. et al. (2025) ‘Updated resources for exploring experimentally-determined PDB structures and Computed Structure Models at the RCSB Protein Data Bank’, Nucleic Acids Research, 53(D1), pp. D564–D574. Available at: https://doi.org/10.1093/nar/gkae1091.
Carregal, A.P. et al. (2017) ‘Docking-based virtual screening of Brazilian natural compounds using the OOMT as the pharmacological target database’, Journal of Molecular Modeling, 23(4), p. 111. Available at: https://doi.org/10.1007/s00894-017-3253-8.
Cavasotto, C. and Singh, N. (2008) ‘Docking and High Throughput Docking: Successes and the Challenge of Protein Flexibility’, Current Computer Aided-Drug Design, 4(3), pp. 221–234. Available at: https://doi.org/10.2174/157340908785747474.
Che, X. and Zhang, L. (2025) ‘Blind docking methods have been inappropriately used in most network pharmacology analysis.’, Frontiers in pharmacology, 16, p. 1566772. Available at: https://doi.org/10.3389/fphar.2025.1566772.
Chen, G., Seukep, A.J. and Guo, M. (2020) ‘Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs’, Marine Drugs, 18(11), p. 545. Available at: https://doi.org/10.3390/md18110545.
Chen, K. and Kurgan, L. (2009) ‘Investigation of Atomic Level Patterns in Protein—Small Ligand Interactions’, PLoS ONE. Edited by B. Kobe, 4(2), p. e4473. Available at: https://doi.org/10.1371/journal.pone.0004473.
Daina, A., Michielin, O. and Zoete, V. (2017) ‘SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules’, Scientific Reports, 7(1), p. 42717. Available at: https://doi.org/10.1038/srep42717.
Derewenda, Z.S. (2023) ‘C-H Groups as Donors in Hydrogen Bonds: A Historical Overview and Occurrence in Proteins and Nucleic Acids’, International Journal of Molecular Sciences, 24(17), p. 13165. Available at: https://doi.org/10.3390/ijms241713165.
Ding, Y. et al. (2016) ‘Assessing the similarity of ligand binding conformations with the Contact Mode Score’, Computational Biology and Chemistry, 64, pp. 403–413. Available at: https://doi.org/10.1016/j.compbiolchem.2016.08.007.
Djinovic-Carugo, K. and Carugo, O. (2015) ‘Missing strings of residues in protein crystal structures’, Intrinsically Disordered Proteins, 3(1), p. e1095697. Available at: https://doi.org/10.1080/21690707.2015.1095697.
Dubach, V.R.A. and Guskov, A. (2020) ‘The Resolution in X-ray Crystallography and Single-Particle Cryogenic Electron Microscopy’, Crystals, 10(7), p. 580. Available at: https://doi.org/10.3390/cryst10070580.
Evteev, S. et al. (2026) ‘AlphaFold Kinase Optimizer: Enhancing Virtual Screening Performance Through Automated Refinement of AlphaFold ‐Based Kinase Structures’, Proteins: Structure, Function, and Bioinformatics, 94(2), pp. 598–608. Available at: https://doi.org/10.1002/prot.70056.
Fawcett, T. (2006) ‘An introduction to ROC analysis’, Pattern Recognition Letters, 27(8), pp. 861–874. Available at: https://doi.org/10.1016/j.patrec.2005.10.010.
Ferreira de Freitas, R. and Schapira, M. (2017) ‘A systematic analysis of atomic protein–ligand interactions in the PDB’, MedChemComm, 8(10), pp. 1970–1981. Available at: https://doi.org/10.1039/C7MD00381A.
Ferreira, L. et al. (2015) ‘Molecular Docking and Structure-Based Drug Design Strategies’, Molecules, 20(7), pp. 13384–13421. Available at: https://doi.org/10.3390/molecules200713384.
Gaulton, A. et al. (2017) ‘The ChEMBL database in 2017’, Nucleic Acids Research, 45(D1), pp. D945–D954. Available at: https://doi.org/10.1093/nar/gkw1074.
Ghersi, D. and Sanchez, R. (2009) ‘Improving accuracy and efficiency of blind protein‐ligand docking by focusing on predicted binding sites’, Proteins: Structure, Function, and Bioinformatics, 74(2), pp. 417–424. Available at: https://doi.org/10.1002/prot.22154.
Gorgulla, C. et al. (2022) ‘Emerging frontiers in virtual drug discovery: From quantum mechanical methods to deep learning approaches’, Current Opinion in Chemical Biology, 69, p. 102156. Available at: https://doi.org/10.1016/j.cbpa.2022.102156.
Grinter, S. and Zou, X. (2014) ‘Challenges, Applications, and Recent Advances of Protein-Ligand Docking in Structure-Based Drug Design’, Molecules, 19(7), pp. 10150–10176. Available at: https://doi.org/10.3390/molecules190710150.
Guedes, I.A., Pereira, F.S.S. and Dardenne, L.E. (2018) ‘Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges’, Frontiers in Pharmacology, 9. Available at: https://doi.org/10.3389/fphar.2018.01089.
Hevener, K.E. et al. (2009) ‘Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase’, Journal of Chemical Information and Modeling, 49(2), pp. 444–460. Available at: https://doi.org/10.1021/ci800293n.
Hingorani, A.D. et al. (2019) ‘Improving the odds of drug development success through human genomics: modelling study’, Scientific Reports, 9(1), p. 18911. Available at: https://doi.org/10.1038/s41598-019-54849-w.
Holcomb, M. et al. (2023) ‘Evaluation of AlphaFold2 structures as docking targets’, Protein Science, 32(1). Available at: https://doi.org/10.1002/pro.4530.
Huang, S.-Y., Grinter, S.Z. and Zou, X. (2010) ‘Scoring functions and their evaluation methods for protein–ligand docking: recent advances and future directions’, Physical Chemistry Chemical Physics, 12(40), p. 12899. Available at: https://doi.org/10.1039/c0cp00151a.
Huang, S.-Y. and Zou, X. (2010a) ‘Advances and Challenges in Protein-Ligand Docking’, International Journal of Molecular Sciences, 11(8), pp. 3016–3034. Available at: https://doi.org/10.3390/ijms11083016.
Huang, S.-Y. and Zou, X. (2010b) ‘Inclusion of Solvation and Entropy in the Knowledge-Based Scoring Function for Protein−Ligand Interactions’, Journal of Chemical Information and Modeling, 50(2), pp. 262–273. Available at: https://doi.org/10.1021/ci9002987.
Illahi, A.D. et al. (2024) ‘In Silico Study of Active Compounds and Protein Targets of Orthosiphon aristatus as Alternative Therapy for Hypertension: Network Pharmacology and Docking’, Eduvest - Journal of Universal Studies, 4(11), pp. 10130–10148. Available at: https://doi.org/10.59188/eduvest.v4i11.1466.
Joshi, A., Bhojwani, H. and Joshi, U. (2019) ‘Selection of Best Crystal Strcuture for Initiating Docking-Based Virtual Screening Studeies of CDK2 Inhibtors: A cross-Docking and DUD Set Validation Approach’, Indian Drugs, 56(06), pp. 77–85. Available at: https://doi.org/10.53879/id.56.06.11592.
Jumper, J. et al. (2021) ‘Highly accurate protein structure prediction with AlphaFold’, Nature, 596(7873), pp. 583–589. Available at: https://doi.org/10.1038/s41586-021-03819-2.
Karelina, M., Noh, J.J. and Dror, R.O. (2023) ‘How accurately can one predict drug binding modes using AlphaFold models?’, eLife, 12. Available at: https://doi.org/10.7554/eLife.89386.
Kim, S. et al. (2025) ‘PubChem 2025 update’, Nucleic Acids Research, 53(D1), pp. D1516–D1525. Available at: https://doi.org/10.1093/nar/gkae1059.
Kingdon, A.D.H. and Alderwick, L.J. (2021) ‘Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis’, Computational and Structural Biotechnology Journal, 19, pp. 3708–3719. Available at: https://doi.org/10.1016/j.csbj.2021.06.034.
Kittelson, K.S. et al. (2026) ‘Reproducibility, validation, and failure modes across classical and AI-driven molecular docking’, Journal of Computer-Aided Molecular Design, 40(1), p. 137. Available at: https://doi.org/10.1007/s10822-026-00849-8.
Kumar, A. and Zhang, K.Y.J. (2018) ‘A cross docking pipeline for improving pose prediction and virtual screening performance’, Journal of Computer-Aided Molecular Design, 32(1), pp. 163–173. Available at: https://doi.org/10.1007/s10822-017-0048-z.
Li, J., Fu, A. and Zhang, L. (2019) ‘An Overview of Scoring Functions Used for Protein–Ligand Interactions in Molecular Docking’, Interdisciplinary Sciences: Computational Life Sciences, 11(2), pp. 320–328. Available at: https://doi.org/10.1007/s12539-019-00327-w.
Liao, J. et al. (2022) ‘In Silico Methods for Identification of Potential Active Sites of Therapeutic Targets’, Molecules, 27(20), p. 7103. Available at: https://doi.org/10.3390/molecules27207103.
Lin, Xiaoqian, Li, X. and Lin, Xubo (2020) ‘A Review on Applications of Computational Methods in Drug Screening and Design’, Molecules, 25(6), p. 1375. Available at: https://doi.org/10.3390/molecules25061375.
Llop-Peiró, A. et al. (2024) ‘Are protein–ligand docking programs good enough to predict experimental poses of noncovalent ligands bound to the SARS-CoV-2 main protease?’, Drug Discovery Today, 29(10), p. 104137. Available at: https://doi.org/10.1016/j.drudis.2024.104137.
Lohning, A.E. et al. (2017) ‘A Practical Guide to Molecular Docking and Homology Modelling for Medicinal Chemists’, Current Topics in Medicinal Chemistry, 17(18). Available at: https://doi.org/10.2174/1568026617666170130110827.
Ma, Z., Ajibade, A. and Zou, X. (2024) ‘Docking strategies for predicting protein-ligand interactions and their application to structure-based drug design’, Communications in Information and Systems, 24(3), pp. 199–230. Available at: https://doi.org/10.4310/CIS.241021221101.
Maidanik, H. et al. (2026) ‘Assessment of Alphafold Protein Models for Small-Molecule Ligand Docking versus Co-Folding’, Journal of Chemical Information and Modeling, 66(10), pp. 5811–5823. Available at: https://doi.org/10.1021/acs.jcim.6c01038.
Makambwa, E. et al. (2025) ‘Virtual Screening of the Zimbawe Natural Product Database for Glucokinase Activators’, Asian Journal of Pharmaceutical and Clinical Research, pp. 56–67. Available at: https://doi.org/10.22159/ajpcr.2025v18i1.53258.
Martis, E.A.F. and Téletchéa, S. (2025) ‘Ten quick tips to perform meaningful and reproducible molecular docking calculations’, PLOS Computational Biology. Edited by P.M. Palagi, 21(5), p. e1013030. Available at: https://doi.org/10.1371/journal.pcbi.1013030.
Mateev, E. et al. (2021) ‘Validation Thriugh Re-docking Cross-docking and Ligand Enrichment in Various Well-Resoluted MAO-B Receptors’, International Journal of Pharmaceutical Sciences and Research, 13, p. 1099. Available at: https://doi.org/10.13040/IJPSR.0975-8232.13(3).1099-07.
Meng, X.-Y. et al. (2011) ‘Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery’, Current Computer Aided-Drug Design, 7(2), pp. 146–157. Available at: https://doi.org/10.2174/157340911795677602.
Milisavljević, A. et al. (2025) ‘Cheminformatic analysis of protein surfaces provides binding site insights and informs identification strategies’, Future Medicinal Chemistry, 17(24), pp. 2945–2958. Available at: https://doi.org/10.1080/17568919.2025.2592531.
Mirzaei, H. et al. (2015) ‘Energy Minimization on Manifolds for Docking Flexible Molecules’, Journal of Chemical Theory and Computation, 11(3), pp. 1063–1076. Available at: https://doi.org/10.1021/ct500155t.
Mohanty, M. and Mohanty, P.S. (2023) ‘Molecular docking in organic, inorganic, and hybrid systems: a tutorial review’, Monatshefte für Chemie - Chemical Monthly, 154(7), pp. 683–707. Available at: https://doi.org/10.1007/s00706-023-03076-1.
Muhammed, M.T. and Aki-Yalcin, E. (2024) ‘Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery’, Letters in Drug Design & Discovery, 21(3), pp. 480–495. Available at: https://doi.org/10.2174/1570180819666220922103109.
Mukherjee, S., Balius, T.E. and Rizzo, R.C. (2010) ‘Docking Validation Resources: Protein Family and Ligand Flexibility Experiments’, Journal of Chemical Information and Modeling, 50(11), pp. 1986–2000. Available at: https://doi.org/10.1021/ci1001982.
Naderi, M. et al. (2019) ‘Binding site matching in rational drug design: algorithms and applications’, Briefings in Bioinformatics, 20(6), pp. 2167–2184. Available at: https://doi.org/10.1093/bib/bby078.
Nivatya, H.K. et al. (2025) ‘Assessing molecular docking tools: understanding drug discovery and design’, Future Journal of Pharmaceutical Sciences, 11(1), p. 111. Available at: https://doi.org/10.1186/s43094-025-00862-y.
Ouma, R.B.O., Ngari, S.M. and Kibet, J.K. (2024) ‘A review of the current trends in computational approaches in drug design and metabolism’, Discover Public Health, 21(1), p. 108. Available at: https://doi.org/10.1186/s12982-024-00229-3.
Paggi, J.M., Pandit, A. and Dror, R.O. (2024) ‘The Art and Science of Molecular Docking’, Annual Review of Biochemistry, 93(1), pp. 389–410. Available at: https://doi.org/10.1146/annurev-biochem-030222-120000.
Pason, L.P. and Sotriffer, C.A. (2016) ‘Empirical Scoring Functions for Affinity Prediction of Protein‐ligand Complexes’, Molecular Informatics, 35(11–12), pp. 541–548. Available at: https://doi.org/10.1002/minf.201600048.
Pellicani, F. et al. (2023) ‘Machine Learning Scoring Functions for Drug Discovery from Experimental and Computer-Generated Protein–Ligand Structures: Towards Per-Target Scoring Functions’, Molecules, 28(4), p. 1661. Available at: https://doi.org/10.3390/molecules28041661.
Prieto, J.M. et al. (2026) ‘Best Practices in Mixed-Solvent Molecular Dynamics and Solvent-Site-Biased Docking’, Journal of Chemical Information and Modeling, 66(7), pp. 3437–3455. Available at: https://doi.org/10.1021/acs.jcim.6c00082.
Puelles, A.A. et al. (2024) ‘Virtual Screening’, in, pp. 209–236. Available at: https://doi.org/10.4018/979-8-3693-3192-7.ch007.
Pun, F.W., Ozerov, I. V. and Zhavoronkov, A. (2023) ‘AI-powered therapeutic target discovery’, Trends in Pharmacological Sciences, 44(9), pp. 561–572. Available at: https://doi.org/10.1016/j.tips.2023.06.010.
Ramírez, D. and Caballero, J. (2018) ‘Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?’, Molecules, 23(5), p. 1038. Available at: https://doi.org/10.3390/molecules23051038.
Rastelli, G. and Pinzi, L. (2019) ‘Refinement and Rescoring of Virtual Screening Results’, Frontiers in Chemistry, 7. Available at: https://doi.org/10.3389/fchem.2019.00498.
Roomi, M.S. et al. (2025) ‘Docking in the Dark: Insights into Protein–Protein and Protein–Ligand Blind Docking’, Pharmaceuticals, 18(12), p. 1777. Available at: https://doi.org/10.3390/ph18121777.
Sabe, V.T. et al. (2021) ‘Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review’, European Journal of Medicinal Chemistry, 224, p. 113705. Available at: https://doi.org/10.1016/J.EJMECH.2021.113705.
Sakano, T. et al. (2016) ‘Molecular dynamics analysis to evaluate docking pose prediction’, Biophysics and Physicobiology, 13, pp. 181–194. Available at: https://doi.org/10.2142/biophysico.13.0_181.
Salentin, S. et al. (2014) ‘Polypharmacology rescored: Protein–ligand interaction profiles for remote binding site similarity assessment’, Progress in Biophysics and Molecular Biology, 116(2–3), pp. 174–186. Available at: https://doi.org/10.1016/j.pbiomolbio.2014.05.006.
Salmaso, V. et al. (2018) ‘Combining self- and cross-docking as benchmark tools: the performance of DockBench in the D3R Grand Challenge 2’, Journal of Computer-Aided Molecular Design, 32(1), pp. 251–264. Available at: https://doi.org/10.1007/s10822-017-0051-4.
Salmaso, V. and Moro, S. (2018) ‘Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview’, Frontiers in Pharmacology, 9. Available at: https://doi.org/10.3389/fphar.2018.00923.
Sapundzhi, F., Prodanova, K. and Lazarova, M. (2019) ‘Survey of the scoring functions for protein-ligand docking’, in, p. 100008. Available at: https://doi.org/10.1063/1.5133601.
Scantlebury, J. et al. (2023) ‘A Small Step Toward Generalizability: Training a Machine Learning Scoring Function for Structure-Based Virtual Screening’, Journal of Chemical Information and Modeling, 63(10), pp. 2960–2974. Available at: https://doi.org/10.1021/acs.jcim.3c00322.
Schuhmacher, A., Gassmann, O. and Hinder, M. (2016) ‘Changing R&D models in research-based pharmaceutical companies’, Journal of Translational Medicine, 14(1), p. 105. Available at: https://doi.org/10.1186/s12967-016-0838-4.
Schwalbe, H. et al. (2024) ‘The future of integrated structural biology’, Structure, 32(10), pp. 1563–1580. Available at: https://doi.org/10.1016/j.str.2024.08.014.
Shareef, U. et al. (2024) ‘A comprehensive review of discovery and development of drugs discovered from 2020–2022’, Saudi Pharmaceutical Journal, 32(1), p. 101913. Available at: https://doi.org/10.1016/j.jsps.2023.101913.
Singh, N. et al. (2023) ‘Drug discovery and development: introduction to the general public and patient groups’, Frontiers in Drug Discovery, 3. Available at: https://doi.org/10.3389/fddsv.2023.1201419.
Sobolev, O. V. et al. (2020) ‘A Global Ramachandran Score Identifies Protein Structures with Unlikely Stereochemistry’, Structure, 28(11), pp. 1249-1258.e2. Available at: https://doi.org/10.1016/j.str.2020.08.005.
Stigliani, J.-L. et al. (2012) ‘Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations’, Organic & Biomolecular Chemistry, 10(31), pp. 6341–6349. Available at: https://doi.org/10.1039/C2OB25602A.
Sun, D. et al. (2022) ‘Why 90% of clinical drug development fails and how to improve it?’, Acta Pharmaceutica Sinica B, 12(7), pp. 3049–3062. Available at: https://doi.org/10.1016/j.apsb.2022.02.002.
Sutherland, J.J. et al. (2007) ‘Lessons in Molecular Recognition. 2. Assessing and Improving Cross-Docking Accuracy’, Journal of Chemical Information and Modeling, 47(6), pp. 2293–2302. Available at: https://doi.org/10.1021/ci700253h.
Tingle, B.I. et al. (2023) ‘ZINC-22─A Free Multi-Billion-Scale Database of Tangible Compounds for Ligand Discovery’, Journal of Chemical Information and Modeling, 63(4), pp. 1166–1176. Available at: https://doi.org/10.1021/acs.jcim.2c01253.
Triadisti, N. et al. (2025) ‘α-Glucosidase inhibitor compounds of Uncaria sclerophylla leaves’ most active chromatography fraction: In vitro, in silico, and ADMET analysis’, Journal of Applied Pharmaceutical Science [Preprint]. Available at: https://doi.org/10.7324/JAPS.2025.215871.
Vaidyanathan, R. et al. (2023) ‘Molecular docking approach on the binding stability of derivatives of phenolic acids (DPAs) with Human Serum Albumin (HSA): Hydrogen-bonding versus hydrophobic interactions or combined influences?’, JCIS Open, 12, p. 100096. Available at: https://doi.org/10.1016/j.jciso.2023.100096.
Villoutreix, B.O. (2021) ‘Post-Pandemic Drug Discovery and Development: Facing Present and Future Challenges’, Frontiers in Drug Discovery, 1. Available at: https://doi.org/10.3389/fddsv.2021.728469.
Wang, J.-C. and Lin, J.-H. (2013) ‘Scoring Functions for Prediction of Protein-Ligand Interactions’, Current Pharmaceutical Design, 19(12), pp. 2174–2182. Available at: https://doi.org/10.2174/1381612811319120005.
Xia, Y., Pan, X. and Shen, H.-B. (2024) ‘A comprehensive survey on protein-ligand binding site prediction’, Current Opinion in Structural Biology, 86, p. 102793. Available at: https://doi.org/10.1016/j.sbi.2024.102793.
Yang, C., Chen, E.A. and Zhang, Y. (2022) ‘Protein–Ligand Docking in the Machine-Learning Era’, Molecules, 27(14), p. 4568. Available at: https://doi.org/10.3390/molecules27144568.
Yin, S. et al. (2008) ‘MedusaScore: An Accurate Force Field-Based Scoring Function for Virtual Drug Screening’, Journal of Chemical Information and Modeling, 48(8), pp. 1656–1662. Available at: https://doi.org/10.1021/ci8001167.
Zhu, H. et al. (2022) ‘A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years’, International Journal of Molecular Sciences, 23(24), p. 15961. Available at: https://doi.org/10.3390/ijms232415961.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Adha Dastu Illahi, Tifany Maulida Candra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
